Table 1 Cox regression analysis for OS in ccRCC patients
From: Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma
Parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Age | 1.03 | 1.01–1.04 | 0.005 | 1.04 | 1.02–1.06 | 1.20 × 10− 4 |
Gender | 1.02 | 0.68–1.55 | 0.912 |  |  |  |
Stage | 1.82 | 1.50–2.20 | 5.93 × 10− 10 | 1.30 | 0.80–2.09 | 0.287 |
T | 1.85 | 1.47–2.33 | 1.82 × 10− 7 | 1.11 | 0.73–1.71 | 0.621 |
N | 3.40 | 1.81–6.41 | 1.50 × 10− 4 | 1.64 | 0.83–3.24 | 0.153 |
M | 4.07 | 2.63–6.29 | 2.49 × 10− 10 | 2.36 | 1.11-5.00 | 0.025 |
DBF4 Expression | 2.17 | 1.43–3.29 | 2.83 × 10− 4 | 2.17 | 1.34–3.50 | 1.51 × 10− 3 |